did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9781444330649

Critical Pathways to Success in CNS Drug Development

by ; ; ; ; ;
  • ISBN13:

    9781444330649

  • ISBN10:

    1444330640

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2010-04-26
  • Publisher: Wiley-Blackwell

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
  • Write a Review Icon Write a Review
List Price: $205.06 Save up to $75.87
  • Rent Book $129.19
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-4 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Clinical Pathways to Success in CNS Drug Development provides a thorough overview of the critical early CNS drug development process for clinical scientists and reviews the latest models, technologies and regulations designed to improve and expedite the drug development process on each of the major CNS disorders. It includes a critical analysis of the lack of CNS specific drugs successfully brought to market and the steps required to remedy this problem. The book covers all of the initial stages of CNS drug development, from pre-clinical to early clinical trials, and includes all the latest technologies, methods, biomarkers, models and regulations designed to accelerate the early CNS drug development process, reduce overall costs, and improve drug safety and efficacy. It also discusses the many inherent difficulties in developing CNS-specific drugs, and describes the many technical and methodological advances used to circumvent these difficulties.

Author Biography

Dr. Neal R. Cutler, Founder and Chairman of Worldwide Clinical Trials, Inc. Previous positions include Deputy Clinical Director of the National Institute on Aging, and Chief, Section on Brain Aging and Dementia. He is currently President of the American Foundation for Clinical Pharmacology.

Dr. John J. Sramek, Director of Clinical Research at Alamo Pharmaceuticals.

Dr Michael F. Murphy, Chief Medical and Scientific Officer, Worldwide Clinical Trials, Inc.

Dr Henry J. Riordan, Senior Vice President, Medical and Scientific Affairs, Worldwide Clinical Trials, Inc.

Dr Peter Biek, Department of Clinical Research, Worldwide Clinical Trials

Dr Angelico Carta, Cedra Clinical Research LLC

Table of Contents

Acknowledgmentsp. vi
Forewordp. vii
The impending crisis in CNS drug developmentp. 1
Animal models and procedures for CNS disordersp. 14
Preclinical antecedents to early human clinical trialsp. 70
Biomarkers and surrogate markers in drug developmentp. 101
Neuroimaging and cognitive assessments in early drug developmentp. 167
Bridging and CSF studiesp. 187
A case study from preclinical to early clinical trialsp. 230
Indexp. 254
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program